Cysteine-containing Protein

Cysteine-containing proteins represent a vast and functionally diverse group of biomolecules defined by the presence of the sulfur-containing amino acid cysteine. Cysteine is unique among the standard amino acids due to its highly reactive thiol (-SH) side chain, which allows for the formation of stabilizing disulfide bridges and facilitates critical biochemical processes such as enzymatic catalysis, metal ion coordination (e.g., in zinc finger motifs), and redox signaling. In the field of drug discovery, this class is of paramount importance because reactive cysteines serve as the primary sites for covalent drug attachment. Covalent inhibitors, such as ibrutinib and sotorasib, utilize electrophilic "warheads" to form irreversible bonds with specific cysteine residues in their targets, providing high potency and a prolonged duration of action. While nearly 90% of the human proteome consists of cysteine-containing proteins, therapeutic efforts focus on "ligandable" cysteines that are accessible and reactive within disease-relevant proteins like kinases and GTPases. However, the broad distribution of cysteines across the proteome poses significant challenges for drug selectivity, as off-target covalent modifications can lead to toxicity or immunogenic responses.

Other names

Thiol-containing proteinsCysteine-rich proteinsCys-containing proteinsCysteine-sensitive proteins

Covalent inhibition of specific reactive cysteine residues via electrophilic warheads, typically through Michael addition or nucleophilic substitution, leading to irreversible protein inactivation.